
Joel Rurik: CAR-T Therapies to Reverse Cardiac Fibrosis
Talking Biotech with Dr. Kevin Folta
00:00
Is Fibrosis a Cancer?
We're hoping for about three to five years to start the first trials. We can use this a a tool to start understanding what fibrosis really means in the disease context. It modularizes treatment for really severe disease that currently doesn't have a treatment. And, you know, i think it really democratizes carte therapy.
Transcript
Play full episode